Skip to main content
. 2022 Mar;11(3):420–431. doi: 10.21037/tlcr-22-190

Figure 2.

Figure 2

Disease-free survival (DFS) in non-mucinous adenocarcinoma (IMA) and non-mucinous adenocarcinoma (NMA) group. Shown are Kaplan-Meier curves estimates of DFS between patients with IMA and NMA before (A) and after (B) propensity score matching (PSM).